A Randomized, Open-label, Phase 2 Study to Evaluate Safety and Efficacy of DUR-928 in Subjects with Primary Sclerosing Cholangitis (PSC)
This Study is
No Longer Enrolling
DUR-928 (investigational drug)
Adult
Diagnosis of PSC
II - Research Studies that gather preliminary data on whether a drug works in people who have a certain condition/disease (that is, the drug's effectiveness). For example, participants receiving the drug may be compared to similar participants receiving a different treatment, usually an inactive substance (called a placebo) or a different drug. Safety continues to be evaluated, and short-term adverse events are studied.
Treatment
University of Colorado Hospital
Protocol Number: 18-0123
More information available at ClinicalTrials.gov: NCT03394781
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers